医学
支气管扩张
肺炎
放射性武器
2019年冠状病毒病(COVID-19)
重症监护医学
弥漫性肺泡损伤
慢性支气管炎
放射科
隐源性机化性肺炎
肺纤维化
肺
急性呼吸窘迫
疾病
病理
内科学
传染病(医学专业)
作者
Raya Tcheroyan,Peter Makhoul,Scott Simpson
标识
DOI:10.1097/mcp.0000000000001152
摘要
Purpose of review Significant progress has been made in our understanding of the acute and chronic clinical and radiological manifestations of coronavirus-19 (COVID-19). This article provides an updated review on pulmonary COVID-19, while highlighting the key imaging features that can identify and distinguish acute COVID-19 pneumonia and its chronic sequelae from other diseases. Recent findings Acute COVID-19 pneumonia typically presents with manifestations of organizing pneumonia on computed tomography (CT). In cases of severe disease, patients clinically progress to acute respiratory distress syndrome, which manifests as diffuse alveolar damage on CT. The most common chronic imaging finding is ground-glass opacities, which commonly resolves, as well as subpleural bands and reticulation. Pulmonary fibrosis is an overall rare complication of COVID-19, with characteristic features, including architectural distortion, and traction bronchiectasis. Summary Chest CT can be a helpful adjunct tool in both diagnosing and managing acute COVID-19 pneumonia and its chronic sequelae. It can identify high-risk cases and guide decision-making, particularly in cases of severe or complicated disease. Follow-up imaging can detect persistent lung abnormalities associated with long COVID and guide appropriate management.
科研通智能强力驱动
Strongly Powered by AbleSci AI